Ischemic postconditioning: From receptor to end-effector

Antioxidants and Redox Signaling

Volumn 14, Issue 5, 2011, Pages 821-831

  Cohen, Michael V ^a   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE A2B RECEPTOR; ADENOSINE TRIPHOSPHATE; GLYCOGEN SYNTHASE KINASE 3BETA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE;

ACIDOSIS; CELL DEATH; CELL PH; CORONARY ARTERY OBSTRUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; MITOCHONDRIAL PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; FREE RADICAL SCAVENGERS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; HYDROGEN-ION CONCENTRATION; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; OXIDATION-REDUCTION; PROTEIN KINASE C; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION;

EID: 79551675869     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3318     Document Type: Review

References (78)

1. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, and Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 111: 194-197, 2005.
2. Baines CP. The molecular composition of the mitochondrial permeability transition pore. J Mol Cell Cardiol 46: 850-857, 2009.
3. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, and Molkentin JD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 9: 550-555, 2007.
4. Cohen MV, Yang X-M, and Downey JM. Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditionings success. Basic Res Cardiol 103: 464-471, 2008.
5. Cohen MV, Yang X-M, and Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115: 1895-1903, 2007.
6. Costa ADT and Garlid KD. Intramitochondrial signaling: interactions among mitoKATP, PKCE, ROS, and MPT. Am J Physiol 295: H874-H882, 2008.
7. Costa ADT, Garlid KD, West IC, Lincoln TM, Downey JM, Cohen MV, and Critz SD. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97: 329-336, 2005.
8. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341: 233-249, 1999.
9. Di Lisa F, Menabò R, Canton M, Barile M, and Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 276: 2571-2575, 2001.
10. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
11. Downey JM and Cohen MV. A really radical observation: a comment on Penna et al. in Basic Res Cardiol (2006) 101:180.
12. Basic Res Cardiol 101: 190-191, 2006.
13. Downey JM, Krieg T, and Cohen MV. Mapping preconditionings signaling pathways: an engineering approach. Ann NY Acad Sci 1123: 187-196, 2008.
14. Eckle T, Krahn T, Grenz A, Köhler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, and Eltzschig HK. Cardioprotection by ecto-50-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590, 2007.
15. Feoktistov I and Biaggioni I. Adenosine A2B receptors. Pharmacol Rev 49: 381-402, 1997.
16. Fujita M, Asanuma H, Hirata A, Wakeno M, Takahama H, Sasaki H, Kim J, Takashima S, Tsukamoto O, Minamino T, Shinozaki Y, Tomoike H, Hori M, and Kitakaze M. Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. Am J Physiol 292: H2004-H2008, 2007.
17. Gao F, Gao E, Yue T-L, Ohlstein EH, Lopez BL, Christopher TA, and Ma X-L. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105: 1497-1502, 2002.
18. Gao Z-G and Jacobson KA. Emerging adenosine receptor agonists. Expert Opin Emerg Drugs 12: 479-492, 2007.
19. Giorgio V, Soriano ME, Basso E, Bisetto E, Lippe G, Forte MA, and Bernardi P. Cyclophilin D in mitochondrial pathophysiology. Biochim Biophys Acta 1797: 1113-1118, 2010.
20. Gomez L, Paillard M, Thibault H, Derumeaux G, and Ovize M. Inhibition of GSK3b by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 117: 2761-2768, 2008.
21. Griffiths EJ and Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307: 93-98, 1995.
22. Griffiths EJ and Halestrap AP. Protection by cyclosporin A of ischemia=reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol 25: 1461-1469, 1993.
23. Gross ER, Hsu AK, and Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase b inhibition during reperfusion in intact rat hearts. Circ Res 94: 960-966, 2004.
24. Halestrap AP, Clarke SJ, and Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 61: 372-385, 2004.
25. Halestrap AP, Kerr PM, Javadov S, and Woodfield K-Y. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1366: 79-94, 1998.
26. Hausenloy DJ, Maddock HL, Baxter GF, and Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55: 534-543, 2002.
27. Hausenloy DJ, Tsang A, Mocanu MM, and Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol 288: H971-H976, 2005.
28. Hausenloy DJ and Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61: 448-460, 2004.
29. Hunter DR, Haworth RA, and Southard JH. Relationship between configuration, function, and permeability in calcium-treated mitochondria. J Biol Chem 251: 5069-5077, 1976.
30. Inserte J, Ruiz-Meana M, Rodriguez-Sinovas A, Barba I, and Garcia-Dorado D. Contribution of delayed intracellular pH recovery to ischemic postconditioning protection. Antioxid Redox Signal 14: 923-939, 2011.
31. Juhaszova M, Zorov DB, Kim S-H, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, and Sollott SJ. Glycogen synthase kinase-3b mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113: 1535-1549, 2004.
32. Kin H, Zatta AJ, Lofye MT, Amerson BS, Halkos ME, Kerendi F, Zhao Z-Q, Guyton RA, Headrick JP, and Vinten-Johansen J. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 67: 124-133, 2005.
33. Kroemer G, Galluzzi L, and Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163, 2007.
34. Kuno A, Critz SD, Cui L, Solodushko V, Yang X-M, Krahn T, Albrecht B, Philipp S, Cohen MV, and Downey JM. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion. J Mol Cell Cardiol 43: 262-271, 2007.
35. Kuno A, Solenkova NV, Solodushko V, Dost T, Liu Y, Yang X-M, Cohen MV, and Downey JM. Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C. Am J Physiol 295: H1288-H1295, 2008.
36. Liu GS, Richards SC, Olsson RA, Mullane K, Walsh RS, and Downey JM. Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res 28: 1057-1061, 1994.
37. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, and Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
38. Liu Y, Yang X, Yang X-M, Walker S, Förster K, Cohen MV, Krieg T, and Downey JM. AMP579 is revealed to be a potent A2b-adenosine receptor agonist in human 293 cells and rabbit hearts. Basic Res Cardiol 105: 129-137, 2010.
39. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J, Jr., and Braunwald E. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 43: 67-82, 1971.
40. Maroko PR, Libby P, Ginks WR, Bloor CM, Shell WE, Sobel BE, and Ross J, Jr. Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest 51: 2710-2716, 1972.
41. Mifune M, Ohtsu H, Suzuki H, Nakashima H, Brailoiu E, Dun NJ, Frank GD, Inagami T, Higashiyama S, Thomas WG, Eckhart AD, Dempsey PJ, and Eguchi S. G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J Biol Chem 280: 26592-26599, 2005.
42. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
43. Mykytenko J, Kerendi F, Reeves JG, Kin H, Zatta AJ, Jiang R, Guyton RA, Vinten-Johansen J, and Zhao Z-Q. Long-term inhibition of myocardial infarction by postconditioning during reperfusion. Basic Res Cardiol 102: 90-100, 2007.
44. Nash MS, Wood JPM, and Osborne NN. Protein kinase C activation by serotonin potentiates agonist-induced stimulation of cAMP production in cultured rat retinal pigment epithelial cells. Exp Eye Res 64: 249-255, 1997.
45. Nicolli A, Basso E, Petronilli V, Wenger RM, and Bernardi P. Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel. J Biol Chem 271: 2185-2192, 1996.
46. Nicolli A, Petronilli V, and Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by matrix pH. Evidence that the pore open-closed probability is regulated by reversible histidine protonation. Biochemistry 32: 4461-4465, 1993.
47. Nishino Y, Webb IG, Davidson SM, Ahmed AI, Clark JE, Jacquet S, Shah AM, Miura T, Yellon DM, Avkiran M, and Marber MS. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res 103: 307-314, 2008.
48. Nordstedt C, Kvanta A, Van der Ploeg I, and Fredholm BB. Dual effects of protein kinase-C on receptor-stimulated cAMP accumulation in a human T-cell leukemia line. Eur J Pharmacol 172: 51-60, 1989.
49. Pain T, Yang X-M, Critz SD, Yue Y, Nakano A, Liu GS, Heusch G, Cohen MV, and Downey JM. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ Res 87: 460-466, 2000.
50. Penna C, Rastaldo R, Mancardi D, Raimondo S, Cappello S, Gattullo D, Losano G, and Pagliaro P. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K channel and protein kinase C activation. Basic Res Cardiol 101: 180-189, 2006.
51. Philipp S, Yang X-M, Cui L, Davis AM, Downey JM, and Cohen MV. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 70: 308-314, 2006.
52. Philipp S, Yang X-M, Willenbrock R, Downey JM, and Cohen MV. Postconditioning must be initiated in less than 1 minute following reperfusion and is dependent on adenosine 2b receptors and PI3-kinase. Z Kardiol 94(Suppl 1): V803, (Abstract)
53. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, GahideG, Finet G, André-Fouët X, Revel D, Kirkorian G, Monassier J-P, Derumeaux G, and Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359: 473-481, 2008.
54. Rodr?́guez-Sinovas A, Cabestrero A, Garća del Blanco B, Inserte J, Garc?́a A, and Garc?́a-Dorado D. Intracoronary acid infusion as an alternative to ischemic postconditioning in pigs. Basic Res Cardiol 104: 761-771, 2009.
55. Schulte G and Fredholm BB. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15: 813-827, 2003.
56. Schwartz LM and Lagranha CJ. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am J Physiol 290: H1011-H1018, 2006.
57. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L, Wang X, MacArthur PH, Shoja A, Raghavachari N, Calvert JW, Brookes PS, Lefer DJ, and Gladwin MT. Nitrite augments tolerance to ischemia=reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 204: 2089-2102, 2007.
58. Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, and Heusch G. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 104: 15-18, 2009.
59. Skyschally A, van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT, and Heusch G. Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 104: 469-483, 2009.
60. Solenkova NV, Solodushko V, Cohen MV, and Downey JM. Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol 290: H441-H449, 2006.
61. Squadrito F, Altavilla D, Squadrito G, Saitta A, Campo GM, Arlotta M, Quartarone C, Ferlito M, and Caputi AP. Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats. Eur J Pharmacol 364: 159-168, 1999.
62. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, LHuillier I, Aupetit J-F, Bonnefoy E, Finet G, André-Fouët X, and Ovize M. Postconditioning the human heart. Circulation 112: 2143-2148, 2005.
63. Sun J, Morgan M, Shen R-F, Steenbergen C, and Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res 101: 1155-1163, 2007.
64. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit J-F, Finet G, André-Fouët X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, and Ovize M. Longterm benefit of postconditioning. Circulation 117: 1037-1044, 2008.
65. Thornton JD, Liu GS, Olsson RA, and Downey JM. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 85: 659-665, 1992.
66. Tissier R, Cohen MV, and Downey JM. Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination? Arch Mal Coeur Vaiss 100: 794-802, 2007.
67. Tong H, Imahashi K, Steenbergen C, and Murphy E. Phosphorylation of glycogen synthase kinase-3b during preconditioning through a phosphatidylinositol-3-kinasedependent pathway is cardioprotective. Circ Res 90: 377-379, 2002.
68. Trincavelli ML, Marroni M, Tuscano D, Ceruti S, Mazzola A, Mitro N, Abbracchio MP, and Martini C. Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells. J Neurochem 91: 1180-1190, 2004.
69. Weinbrenner C, Liu GS, Downey JM, and Cohen MV. Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. Cardiovasc Res 38: 676-684, 1998.
70. Xi J, McIntosh R, Shen X, Lee S, Chanoit G, Criswell H, Zvara DA, and Xu Z. Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol 47: 684-690, 2009.
71. Xu Z, Downey JM, and Cohen MV. AMP 579 reduces contracture and limits infarction in rabbit heart by activating adenosine A2 receptors. J Cardiovasc Pharmacol 38: 474-481, 2001.
72. Yang X-M, Krieg T, Cui L, Downey JM, and Cohen MV. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol 36: 411-421, 2004.
73. Yang X-M, Philipp S, Downey JM, and Cohen MV. Postconditionings protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 100: 57-63, 2005.
74. Yang X-M, Proctor JB, Cui L, Krieg T, Downey JM, and Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 44: 1103-1110, 2004.
75. Ytrehus K, Liu Y, and Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266: H1145-H1152, 1994.
76. Zatta AJ, Kin H, Lee G, Wang N, Jiang R, Lust R, Reeves JG, Mykytenko J, Guyton RA, Zhao Z-Q, and Vinten-Johansen J. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res 70: 315-324, 2006.
77. Zhao Z-Q, Corvera JS, Halkos ME, Kerendi F, Wang N-P, Guyton RA, and Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol 285: H579-H588, 2003.
78. Zorov DB, Juhaszova M, Yaniv Y, Nuss HB, Wang S, and Sollott SJ. Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc Res 83: 213-225, 2009.